Search

Displaying results 3581 - 3590 of 7063 in total
  1. Drug

    Surzetoclax

    go.drugbank.com/drugs/DB21698
    Investigational

    Surzetoclax has a monoisotopic molecular weight of 1038.41 Da. … Surzetoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Surzetoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  2. Drug

    Stirocainide

    go.drugbank.com/drugs/DB20924
    Experimental

    Stirocainide has a monoisotopic molecular weight of 342.27 Da. … Stirocainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Stirocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  3. Drug

    Aceperone

    go.drugbank.com/drugs/DB21172
    Experimental

    Aceperone has a monoisotopic molecular weight of 396.22 Da. … Aceperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Aceperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  4. Drug

    Carocainide

    go.drugbank.com/drugs/DB21207
    Experimental

    Carocainide has a monoisotopic molecular weight of 363.18 Da. … Carocainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Carocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  5. Drug

    Lodiperone

    go.drugbank.com/drugs/DB21210
    Experimental

    Lodiperone has a monoisotopic molecular weight of 435.09 Da. … Lodiperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Lodiperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  6. Drug

    Murocainide

    go.drugbank.com/drugs/DB21243
    Experimental

    Murocainide has a monoisotopic molecular weight of 377.2 Da. … Murocainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Murocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  7. Drug

    Tocilizumab

    go.drugbank.com/drugs/DB06273
    ApprovedInvestigational

    [L44483] Tocilizumab-bavi, a biosimilar drug, was approved by the FDA in September 2023.[L48385]. … [A193281] Tocilizumab was granted FDA approval on 8 January 2010 to treat a number of inflammatory and autoimmune disorders, such as different types of arthritis and cytokine release syndrome.

  8. Drug

    Sedecamycin

    go.drugbank.com/drugs/DB21342
    Experimental

    Sedecamycin has a monoisotopic molecular weight of 501.24 Da. … Sedecamycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Sedecamycin is a antibiotic, produced by Streptomyces strain.

  9. Drug

    Ambasilide

    go.drugbank.com/drugs/DB19463
    Experimental

    Ambasilide has a monoisotopic molecular weight of 335.2 Da. … Ambasilide is a small molecule drug. The usage of the INN stem '-ilide' in the name indicates that Ambasilide is a sematilide derivative class III antiarrhythmic.

  10. Drug

    Bitipazone

    go.drugbank.com/drugs/DB19941
    Experimental

    Bitipazone has a monoisotopic molecular weight of 454.27 Da. … Bitipazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Bitipazone is a anti-inflammatory analgesic, phenylbutazone derivative.